Literature summary for 3.1.6.8 extracted from

Oner-Iyidogan, Y.; Oner, P.; Kocak, H.; Lama, A.; Gurdol, F.; Bekpinar, S.; Unur, N.; Ozbek-Kir, Z.
Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer (2005), Pharmacol. Res., 52, 340-345.

Search for more literature for 3.1.6.8

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	females with breast cancer	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
leukocyte	-	Homo sapiens	-

Specific Activity [micromol/min/mg]

Specific Activity Minimum [µmol/min/mg]	Specific Activity Maximum [µmol/min/mg]	Comment	Organism
0.00086	-	before tamoxifen treatment	Homo sapiens
0.0009	-	3 months after treatment with 40 mg tamoxifen for one week	Homo sapiens
0.0013	-	6 months after treatment with 40 mg tamoxifen for one week	Homo sapiens

Substrates and Products (Substrate)

Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
p-nitrocatechol sulfate + H2O	-	Homo sapiens	p-nitrocatechol + sulfate	-	?

Synonyms

Synonyms	Comment	Organism
arylsulfatase A	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)